Session 21 - Neuroimmunology
SARS-CoV-2 and brain barriers

Programme

• 13:45 – 14:15 25 Min. 5 Min.

  • Invited Talk
  • S21-NI-T1

  Current concepts of brain barriers

  • Steven Proulx (Bern, CH)
• 14:15 – 14:25 7 Min. 3 Min.

  • Abstract Talk
  • S21-NI-A234

  Detection of SARS-CoV-2 viral proteins and genomic sequences in the human brainstem

  • Aron Emmi (Padova, IT)
• 14:25 – 14:35 7 Min. 3 Min.

  • Abstract Talk
  • S21-NI-A235

  Persistence of SARS-CoV-2 in the brain – truth or myth?

  • Josefine Radke (Greifswald, DE)
• 14:35 – 14:45 7 Min. 3 Min.

  • Abstract Talk
  • S21-NI-A236

  Multifactorial white matter damage in the acute phase and pre-existing conditions may drive cognitive dysfunction after SARS-CoV-2 infection – neuropathology-based evidence

  • Ellen Gelpi (Vienna, AT)
• 14:45 – 14:55 7 Min. 3 Min.

  • Abstract Talk
  • S21-NI-A237

  Cerebral intussusceptive angiogenesis – distinct small vessel pathology associated with COVID-19

  • Vincent Umathum (Giessen, DE)
• 14:55 – 15:05 7 Min. 3 Min.

  • Abstract Talk
  • S21-NI-A238

  Post-COVID syndrome is associated with capillary alterations, macrophage infiltration and distinct transcriptomic signatures in skeletal muscles

  • Tom Aschman (Berlin, DE)
• 15:05 – 15:15 7 Min. 3 Min.

  • Abstract Talk
  • S21-NI-A239

  Berlin autopsy study on cause of death upon vaccinations against SARS-CoV-2

  • Helena Radbruch (Berlin, DE)